… squamous transition. Such transition confers lung tumors with drug resistance in mouse
models… This review will summarize current research progress of the transition from lung ADC to …

… to epithelial transition factor (MET) gene alterations involve … -small cell lung cancer with MET
alterations, and resistance to these … Off-target resistance includes activation of MET cascade …

… The common mechanisms of drug resistance include secondary … transformation includes
the transformation from lung ADC to small cell lung cancer (SCLC), squamous cell carcinoma (…

… -epithelial transition factor, MET）长期以来被认为是非小细胞肺癌（non-small cell lung cancer,
NSCLC… In addition, when MET amplification occurs after resistance to EGFR tyrosine kinase …

… cancer is the malignant tumor with the highest morbidity and mortality in China. Non-small cell
lung cancer … , which reflects the latest advances in international lung cancer research. This …

… of these inhibitors is the serious off-target effect due to the … strongly suppress esophageal
squamous cell carcinoma (ESCC) … inhibitors via chemical modifications in lead compounds or …

… cancer centers, aiming to provide a better, more efficient and more appropriate management
model for cancer … experts and cancer patients have access to the latest cancer prevention, …

… in off-target results. However, the developed catalytic oligonucleotides with base modifications
for … play a significant role in cancers such as hepatocellular carcinoma, bladder cancer, …

… status of acquired EGFR-TKI post-drug resistance treatment in patients with advanced lung
… cell lung cancer, SCLC)或肺鳞癌和上皮间质转化(Epithelial-mesenchymal transition, EMT).…

… faces several challenges, including off-target effects, safety concerns, … of lncRNAs in chromatin
modification, transcription, and … analysis reveals the coregulation of RNA-binding proteins …